NT5E and acute lymphoblastic leukemia: Expression of CD73, a surface enzyme expressed on multiple cell types, was evaluated in BCP-ALL patients; 42–70% of BCP-ALL patients showed overexpression of CD73 compared with BCPs [62,70,71,72].